Technical corrections only. The diff updates the attestation information and procedural status of the bill, reflecting its passage in the House and referral to the Senate. No substantive policy changes were made between v2 and v3.
Chronic Disease Flexible Coverage Act
- Sponsor
- Rep. Buchanan, Vern [R-FL-16]
- Committees
- Finance Committee (primary)
- Last action
- Mar 5, 2025
Bottom line
The bill formalizes existing IRS guidance, ensuring that specific chronic disease management services can be covered by HDHPs before the deductible, thereby promoting access to care for individuals with chronic conditions without jeopardizing HSA eligibility.
What it actually does
This bill, titled the 'Chronic Disease Flexible Coverage Act,' codifies existing Internal Revenue Service (IRS) guidance, specifically Notice 2019-45, into law. This guidance allows High Deductible Health Plans (HDHPs) to cover certain services and items for chronic conditions as 'preventive care' without requiring the deductible to be met first. By doing so, individuals with chronic conditions can receive these specific treatments and medications before meeting their deductible, while still maintaining their eligibility to contribute to a Health Savings Account (HSA).
Proponents argue
Supporters argue that codifying IRS Notice 2019-45 provides crucial clarity and permanence for both health plans and individuals, removing financial barriers for those managing chronic diseases. They contend that this encourages adherence to preventive care regimens, which can lead to improved health outcomes, reduced emergency care needs, and potentially lower long-term healthcare costs by preventing complications.
Opponents contend
Direct opposition to this bill is unlikely, as it codifies existing, generally beneficial IRS guidance. However, potential critics might argue that codifying specific administrative guidance could limit future flexibility for the IRS to adapt to evolving healthcare needs or that it represents a piecemeal approach to healthcare reform rather than a comprehensive solution to broader issues within HDHPs or the healthcare system.
The bill is exceptionally short and clearly written, making it very accessible for a quick and thorough evaluation by any interested reader.
Section 2(a)
Codification of IRS Notice 2019-45 for Chronic Disease Preventive Care
This section makes permanent the Internal Revenue Service (IRS) guidance, specifically Notice 2019-45, concerning the treatment of certain services and items for chronic conditions. It mandates that these services and items can be considered 'preventive care' for the purposes of High Deductible Health Plans (HDHPs) linked to Health Savings Accounts (HSAs). This means that HDHPs can cover these specific chronic care services before the deductible is met, without disqualifying an individual from contributing to an HSA.
Supporters argue
Supporters argue this provision removes a significant financial barrier for individuals managing chronic diseases, encouraging consistent adherence to preventive care regimens. This consistency can lead to better health outcomes, reduce the likelihood of costly emergency interventions, and provide much-needed certainty for patients and health plans regarding HSA eligibility.
Critics contend
No specific opposition is typically raised against this provision, as it formalizes existing, widely accepted IRS guidance that is generally seen as beneficial to patients. Any potential opposition would likely stem from broader philosophical disagreements with the structure of HSAs or HDHPs, rather than this specific clarification.
Tradeoffs
The primary tension addressed by this provision is the balance between maintaining the 'high deductible' nature of HDHPs and ensuring that essential preventive care for chronic conditions remains accessible. This bill resolves this tension by explicitly defining specific chronic care services as preventive, thereby allowing pre-deductible coverage without undermining the core HDHP structure or HSA eligibility.
This subsection, titled 'No Inference,' specifies that the codification of IRS Notice 2019-45 should not be interpreted to infer anything about other existing or future rules or guidance provided by the Secretary concerning preventive services for HDHPs, as long as such guidance is not inconsistent with this Act.
Section 2(b)
Why it matters:This is a common legislative drafting technique used to prevent unintended legal interpretations. It aims to limit the scope of the bill's impact on the IRS's broader authority to issue guidance, rather than being an attempt to hide a controversial policy.
Case for: Supporters argue that this clause is essential for preserving the IRS's administrative flexibility. It ensures that while this specific guidance is codified, the agency is not unduly constrained from adapting to new medical advancements or policy needs by issuing further guidance on other preventive services in the future.
Case against: Critics might contend that such 'no inference' clauses can sometimes create ambiguity or provide an opening for future administrative actions that could subtly undermine the spirit of codified laws. However, in this context, the concern is minor, as it primarily protects administrative discretion rather than introducing new policy.
Estimated impact: The impact is primarily on legal interpretation and the scope of future IRS rulemaking authority, rather than immediate policy changes. It ensures the IRS retains flexibility for other preventive care guidance.